רקויפ מודוטאב 4 מ"ג

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

ROPINIROLE AS HYDROCHLORIDE 4 MG

Disponible depuis:

GLAXO SMITH KLINE (ISRAEL) LTD

Code ATC:

N04BC04

forme pharmaceutique:

FILM COATED TABLETS - PROLONGED RELEASE

Mode d'administration:

PER OS

Fabriqué par:

SMITHKLINE BEECHAM PLC, UK

Groupe thérapeutique:

ROPINIROLE

indications thérapeutiques:

Ropinirole is indicated for the treatment of Parkinson's disease. Ropinirole is effective as early therapy in patients requiring dopaminergic therapy. As adjunctive treatment to L-dopa, ropinirole enhances the efficacy of L-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic L-dopa therapy and permits reduction in daily L-dopa dose.

Date de l'autorisation:

2009-09-01